Frequently asked questions Some patients may notice weight loss or blood sugar improvements may start within 24 weeks, but full effects may take 812 weeks
Food and Drug Administration (FDA) found 185 cases of sexual dysfunction reported among users of GLP-1 receptor agonists
Phase 2 clinical trials have demonstrated its long-term safety and efficacy
But here's what many people miss: it's not just about eating more protein
Recent Updates November 21, 2025: Updated Shed information regarding the lower price of premium coaching, the new availability of Wegovy and Zepbound, and the price of the membership program for Wegovy and Zepbound
As would be expected, gastrointestinal events, usually mild to moderate in severity and occurring mostly during dose titration, were the most common adverse events, and occurred with similar frequency with tirzepatide (4045% in SURPASS-2) to that seen with semaglutide (41.2%)